Search

Your search keyword '"Shankar-Hari, Manu"' showing total 1,039 results

Search Constraints

Start Over You searched for: Author "Shankar-Hari, Manu" Remove constraint Author: "Shankar-Hari, Manu"
1,039 results on '"Shankar-Hari, Manu"'

Search Results

202. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

205. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis.

208. Association of cardiometabolic microRNAs with COVID-19 severity and mortality

210. Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics

211. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study

212. Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation

216. Genetic mechanisms of critical illness in Covid-19

217. Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalized patients with COVID-19: A network meta-analysis

218. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study

219. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

221. Defining phenotypes and treatment effect heterogeneity to inform acute respiratory distress syndrome and sepsis trials: secondary analyses of three RCTs

222. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

223. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

224. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

225. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

226. Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections

227. Initial setting of high-flow nasal oxygen post extubation based on mean inspiratory flow during a spontaneous breathing trial

228. Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant

229. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report

230. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

231. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19 : a meta-analysis

232. Mapping the human genetic architecture of COVID-19

233. Association between convalescent plasma treatment and mortality in COVID-19:a collaborative systematic review and meta-analysis of randomized clinical trials

234. Association between convalescent plasma treatment and mortality in COVID-19 : a collaborative systematic review and meta-analysis of randomized clinical trials

235. The COVID-19 puzzle : deciphering pathophysiology and phenotypes of a new disease entity

238. Estimating the attributable fraction of mortality from acute respiratory distress syndrome to inform enrichment in future randomised clinical trials

239. Correction to: COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland

242. Cellular and molecular mechanisms of IMMunE dysfunction and Recovery from SEpsis-related critical illness in adults: An observational cohort study (IMMERSE) protocol paper.

243. Use of dexmedetomidine for sedation in mechanically ventilated adult ICU patients: a rapid practice guideline.

244. Artemisinin inhibits neutrophil and macrophage chemotaxis, cytokine production and NET release.

245. Protocol for a scoping review of sepsis epidemiology.

246. Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial.

247. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

248. Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method

249. Virological and serological characterization of critically ill patients with COVID-19 in the UK: a special focus on variant detection

Catalog

Books, media, physical & digital resources